Visit us at booth #45 for the 25th annual meeting of the European Society of Intensive Care Medicine (ESICM) in Lisbon, Portugal and meet with a Siemens representative to discuss our latest critical care innovations for point-of-care testing. The exhibition hall is open between Monday, October 15 and Wednesday, October 17, 2012. Please go to the congress website for further information.
RAPIDPoint® 500 Blood Gas System
The test menu for our new, cartridge-based, blood gas analyzer has been expanded:
- Now supports pleural fluid pH1 testing
- Lactate1 testing available
- Perform full test menu using dialysate1 fluid samples
In addition, Siemens offers a comprehensive portfolio of blood gas testing solutions to support you from pre-analytical sample collection through analysis, reporting, and beyond. Quality instruments for all test volumes, combined with dedicated service, training and patent-pending education programs, make partnering with Siemens a tremendous value.
Special Preview: Stratus CS® 200 Acute Care™ Analyzer2
Combining a full menu for point of care cardiac testing with lab-quality results, this new analyzer enables rapid decision-making for better patient care:
- 7 assays available: hsTnI3, hsCRP, NTproBNP, Myoglobin, CKMB, D-dimer4, ßhCG
- Strong correlation of results with laboratory analyzers
- Accepts whole blood – no sample preparation needed
Siemens Point of Care (POC) cardiac portfolio delivers lab-accurate results in as little as 14 minutes with minimal user intervention enabling timely and actionable decisions. A recognized leader in cardiovascular disease testing, Siemens provides a comprehensive and expanding menu of cardiac biomarkers across a broad spectrum of instrument solutions that help manage patients throughout the continuum of cardiovascular disease.
Not available for sale in all countries.
Under development. Not available for sale. Future availability cannot be guaranteed.
Defined as an imprecision level of 10% at the 99th percentile of a normal population by the joint ESC/ACC committee
Exclusion of PE in conjunction with non-high PTP model